Active in various situations such as managing the production processes of food manufacturing plants and quality control in pharmaceutical companies!
The "PoCGS-iE" is an automatic Gram staining machine that completes the process from fixation to staining in just 5 minutes. It is compact and space-saving, with no need for additional water supply or drainage facilities. The entire staining process can be automated. Additionally, it can register up to 10 different staining programs and is compatible with general-purpose staining reagents. 【Recommended Use Cases】 ■ For staining in laboratories ■ For maintaining sanitary environments *For more details, please download the PDF or feel free to contact us.
Inquire About This Product
basic information
[Staining Example] ■Staining standard bacterial strains using PoCGS ■Gram-positive cocci ■Gram-positive cocci and Gram-negative bacilli *For more details, please download the PDF or feel free to contact us.*
Price range
Delivery Time
Applications/Examples of results
【Active in such situations】 ■ Management of work processes in food manufacturing factories ■ Maintenance and management of environmental hygiene in food processing factories ■ Creation of standard protocols in basic research laboratories ■ Quality control in pharmaceutical companies ■ Quality control in beverage manufacturers *For more details, please download the PDF or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
CarbGeM Inc. provides digital transformation (DX) and AI solutions specialized in the life sciences and healthcare sectors. Building on capabilities in medical data analysis, image-analysis AI, generative AI, and application development, we work together with academia, medical institutions, and companies to support the full journey from research and development through to real-world implementation. We have particular expertise in developing AI-based Software as a Medical Device (SaMD), navigating regulatory affairs, and establishing Quality Management Systems (QMS), backed by a proven track record of obtaining medical device approvals and notifications. We advance industry-academia partnerships around early-stage AI and data-science research emerging from academia, with technical implementation, clinical application, and commercialization firmly in view. We take the same approach with our corporate partners, pursuing co-creation to move research and new business initiatives forward while keeping technical implementation and regulatory requirements in mind. As a partner in joint research and new business development, we would welcome the opportunity to exchange ideas on areas where our expertise can add value—including data-collection design and the preparation of AI-ready data, DX/AI implementation, and the planning of regulatory and exit strategies. We would also be glad to take an active role in securing funding for joint projects.